Tenecteplase

Proper name: Tenecteplase
Tradename: TNKase
Manufacturer: Genentech, Inc, South San Francisco, CA, License #1048
Indication for Use: Reduction of mortality associated with acute myocardial infarction (AMI)
Approval Date: 6/2/2000
Type of submission: Biologics license application

Approval Letter (PDF), (Text)

Label (PDF), (Text)

Reviews
      Statistical Review - (PDF)
      Clinical Pharmacology and Toxicology Review - (PDF), (Text)
      Clinical Review - (PDF)

Last Updated: 12/10/2001

Back to Top     Back to Index

Updated: September 25, 2003

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page

FDA/Center for Drug Evaluation and Research